Skip to main content

Table 6 Thresholds for treatment calculated using FRAXa and based on LASA cohort data, stratified for age

From: Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Age Total group No clinical risk factors for fractures ≥1 clinical risk factors for fractures Treatment threshold
(yrs) mean FRAX-score (SD) N mean FRAX-score (SD) N Mean FRAX-score (SD) N  
65-69 12.1 (5.2) 166 8.9 (1.3) 83 15.3 (5.6) 83 >15%
70-74 14.7 (5.8) 187 10.9 (1.6) 90 18.3 (6.0) 97 >18%
75-79 18.6 (7.6) 154 13.2 (2.0) 76 24.0 (7.2) 78 >24%
80-84 22.1 (8.1) 157 17.3 (2.8) 86 28.0 (8.6) 71 >28%
85-91 26.2 (8.1) 101 19.4 (3.1) 44 31.5 (6.8) 57 >32%
  1. FRAX fracture risk assessment tool, LASA Longitudinal Aging Study Amsterdam, SD standard deviation
  2. aUK version of the FRAX tool